Structure

Physi-Chem Properties

Molecular Weight:  586.24
Volume:  577.551
LogP:  3.187
LogD:  1.782
LogS:  -4.741
# Rotatable Bonds:  8
TPSA:  144.64
# H-Bond Aceptor:  11
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.282
Synthetic Accessibility Score:  6.484
Fsp3:  0.645
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.273
MDCK Permeability:  6.029053110978566e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.204
20% Bioavailability (F20%):  0.933
30% Bioavailability (F30%):  0.957

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.867
Plasma Protein Binding (PPB):  68.88374328613281%
Volume Distribution (VD):  1.263
Pgp-substrate:  34.74995422363281%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.11
CYP2C19-inhibitor:  0.123
CYP2C19-substrate:  0.329
CYP2C9-inhibitor:  0.436
CYP2C9-substrate:  0.016
CYP2D6-inhibitor:  0.03
CYP2D6-substrate:  0.047
CYP3A4-inhibitor:  0.906
CYP3A4-substrate:  0.905

ADMET: Excretion

Clearance (CL):  2.779
Half-life (T1/2):  0.438

ADMET: Toxicity

hERG Blockers:  0.009
Human Hepatotoxicity (H-HT):  0.664
Drug-inuced Liver Injury (DILI):  0.882
AMES Toxicity:  0.431
Rat Oral Acute Toxicity:  0.974
Maximum Recommended Daily Dose:  0.973
Skin Sensitization:  0.199
Carcinogencity:  0.614
Eye Corrosion:  0.852
Eye Irritation:  0.097
Respiratory Toxicity:  0.914

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC6326

Natural Product ID:  NPC6326
Common Name*:   Cipatrijugin C
IUPAC Name:   n.a.
Synonyms:   Cipatrijugin C
Standard InCHIKey:  VBUVTRXWAVCMCB-YAVIGIRXSA-N
Standard InCHI:  InChI=1S/C31H38O11/c1-16-30(41-18(3)33)15-28(6)25(19-9-10-38-14-19)40-24(35)13-31(16,28)42-22-12-21(39-17(2)32)27(4,5)20(11-23(34)37-8)29(22,7)26(30)36/h9-10,14,20-22,25H,1,11-13,15H2,2-8H3/t20-,21+,22-,25-,28-,29+,30+,31-/m0/s1
SMILES:  C=C1[C@@]2(C[C@@]3(C)[C@H](c4ccoc4)OC(=O)C[C@]13O[C@H]1C[C@H](C(C)(C)[C@H](CC(=O)OC)[C@@]1(C)C2=O)OC(=O)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL252939
PubChem CID:   23626012
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0002966] Tetracarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4584 Cipadessa cinerascens Species Meliaceae Eukaryota leaves n.a. n.a. PMID[17655260]
NPO4584 Cipadessa cinerascens Species Meliaceae Eukaryota Leaves n.a. n.a. PMID[19296669]
NPO4584 Cipadessa cinerascens Species Meliaceae Eukaryota leaves Longlin County of Guangxi Province, China 2012-JUL PMID[25970729]
NPO4584 Cipadessa cinerascens Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 > 5.0 ug ml-1 PMID[476200]
NPT111 Cell Line K562 Homo sapiens ED50 > 5.0 ug ml-1 PMID[476200]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC6326 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9801 High Similarity NPC195131
0.9742 High Similarity NPC476224
0.9735 High Similarity NPC204663
0.9677 High Similarity NPC149945
0.9484 High Similarity NPC472767
0.9367 High Similarity NPC472764
0.9308 High Similarity NPC472766
0.9308 High Similarity NPC472765
0.9114 High Similarity NPC197596
0.9068 High Similarity NPC327922
0.9062 High Similarity NPC478178
0.9057 High Similarity NPC165218
0.9026 High Similarity NPC156189
0.8987 High Similarity NPC237155
0.897 High Similarity NPC478177
0.8963 High Similarity NPC236004
0.8938 High Similarity NPC472669
0.8924 High Similarity NPC472772
0.8924 High Similarity NPC167142
0.8902 High Similarity NPC469848
0.8889 High Similarity NPC478179
0.8875 High Similarity NPC470939
0.8875 High Similarity NPC471166
0.8875 High Similarity NPC471167
0.8875 High Similarity NPC472668
0.8848 High Similarity NPC471437
0.8848 High Similarity NPC471632
0.8848 High Similarity NPC94763
0.8841 High Similarity NPC285227
0.8839 High Similarity NPC470790
0.8839 High Similarity NPC470791
0.8831 High Similarity NPC470941
0.8827 High Similarity NPC214600
0.882 High Similarity NPC224394
0.882 High Similarity NPC663
0.882 High Similarity NPC471168
0.8812 High Similarity NPC191828
0.8805 High Similarity NPC472283
0.8782 High Similarity NPC196864
0.8782 High Similarity NPC477404
0.8782 High Similarity NPC469335
0.8782 High Similarity NPC159927
0.878 High Similarity NPC472659
0.8773 High Similarity NPC476853
0.8773 High Similarity NPC472775
0.8773 High Similarity NPC472774
0.8766 High Similarity NPC262198
0.8758 High Similarity NPC472771
0.875 High Similarity NPC474932
0.875 High Similarity NPC477403
0.8742 High Similarity NPC126723
0.8742 High Similarity NPC263265
0.8727 High Similarity NPC159232
0.8718 High Similarity NPC329180
0.8704 High Similarity NPC472773
0.8696 High Similarity NPC25255
0.8696 High Similarity NPC305016
0.8688 High Similarity NPC286722
0.8688 High Similarity NPC249021
0.8679 High Similarity NPC469850
0.8662 High Similarity NPC476122
0.8659 High Similarity NPC476850
0.8659 High Similarity NPC476861
0.865 High Similarity NPC476856
0.865 High Similarity NPC123088
0.865 High Similarity NPC476858
0.865 High Similarity NPC476857
0.865 High Similarity NPC476860
0.8642 High Similarity NPC193798
0.8634 High Similarity NPC473473
0.8634 High Similarity NPC475295
0.8625 High Similarity NPC60973
0.8625 High Similarity NPC209364
0.8625 High Similarity NPC107646
0.8623 High Similarity NPC469576
0.8598 High Similarity NPC23387
0.859 High Similarity NPC221809
0.8589 High Similarity NPC469846
0.8589 High Similarity NPC469338
0.8589 High Similarity NPC477405
0.8589 High Similarity NPC292389
0.858 High Similarity NPC477402
0.858 High Similarity NPC470789
0.858 High Similarity NPC475381
0.8571 High Similarity NPC45101
0.8571 High Similarity NPC469633
0.8571 High Similarity NPC167340
0.8562 High Similarity NPC469336
0.8562 High Similarity NPC264943
0.8562 High Similarity NPC471175
0.8553 High Similarity NPC476201
0.8545 High Similarity NPC173516
0.8545 High Similarity NPC472651
0.8545 High Similarity NPC473753
0.8545 High Similarity NPC473766
0.8537 High Similarity NPC469849
0.8537 High Similarity NPC276551
0.8537 High Similarity NPC470940
0.8529 High Similarity NPC470938
0.8528 High Similarity NPC69028
0.8528 High Similarity NPC329938
0.8528 High Similarity NPC82851
0.8521 High Similarity NPC470181
0.8509 High Similarity NPC175964
0.8509 High Similarity NPC471169
0.85 High Similarity NPC282445
0.85 High Similarity NPC178932
0.8494 Intermediate Similarity NPC160651
0.8494 Intermediate Similarity NPC472652
0.8494 Intermediate Similarity NPC471397
0.8491 Intermediate Similarity NPC116717
0.8491 Intermediate Similarity NPC18135
0.8488 Intermediate Similarity NPC105395
0.8488 Intermediate Similarity NPC247563
0.8488 Intermediate Similarity NPC242068
0.8485 Intermediate Similarity NPC470875
0.8481 Intermediate Similarity NPC472654
0.8476 Intermediate Similarity NPC302369
0.8476 Intermediate Similarity NPC134254
0.8476 Intermediate Similarity NPC39986
0.8476 Intermediate Similarity NPC476197
0.8466 Intermediate Similarity NPC472653
0.8457 Intermediate Similarity NPC36655
0.8457 Intermediate Similarity NPC261597
0.8452 Intermediate Similarity NPC223415
0.8447 Intermediate Similarity NPC44675
0.8447 Intermediate Similarity NPC476262
0.8447 Intermediate Similarity NPC214541
0.8438 Intermediate Similarity NPC29695
0.8438 Intermediate Similarity NPC469503
0.8438 Intermediate Similarity NPC84063
0.8438 Intermediate Similarity NPC182427
0.8438 Intermediate Similarity NPC75906
0.8434 Intermediate Similarity NPC472282
0.8428 Intermediate Similarity NPC46551
0.8415 Intermediate Similarity NPC263432
0.8415 Intermediate Similarity NPC5079
0.8405 Intermediate Similarity NPC475967
0.8405 Intermediate Similarity NPC472779
0.8397 Intermediate Similarity NPC86935
0.8395 Intermediate Similarity NPC469485
0.8383 Intermediate Similarity NPC271235
0.8383 Intermediate Similarity NPC242334
0.8375 Intermediate Similarity NPC272590
0.8364 Intermediate Similarity NPC51568
0.8364 Intermediate Similarity NPC419
0.8364 Intermediate Similarity NPC234660
0.8354 Intermediate Similarity NPC335761
0.8344 Intermediate Similarity NPC173544
0.8344 Intermediate Similarity NPC469847
0.8344 Intermediate Similarity NPC187149
0.8333 Intermediate Similarity NPC470995
0.8333 Intermediate Similarity NPC75310
0.8323 Intermediate Similarity NPC20500
0.8313 Intermediate Similarity NPC261184
0.8303 Intermediate Similarity NPC117986
0.8303 Intermediate Similarity NPC5741
0.8294 Intermediate Similarity NPC477824
0.8293 Intermediate Similarity NPC475226
0.8291 Intermediate Similarity NPC471292
0.8284 Intermediate Similarity NPC160818
0.8284 Intermediate Similarity NPC169299
0.828 Intermediate Similarity NPC238843
0.828 Intermediate Similarity NPC199044
0.828 Intermediate Similarity NPC142113
0.8272 Intermediate Similarity NPC57998
0.8261 Intermediate Similarity NPC240214
0.8261 Intermediate Similarity NPC291150
0.825 Intermediate Similarity NPC195325
0.8247 Intermediate Similarity NPC476943
0.8242 Intermediate Similarity NPC333139
0.8232 Intermediate Similarity NPC472778
0.8232 Intermediate Similarity NPC299038
0.8232 Intermediate Similarity NPC472777
0.8232 Intermediate Similarity NPC197137
0.8232 Intermediate Similarity NPC472776
0.8232 Intermediate Similarity NPC470118
0.8232 Intermediate Similarity NPC475066
0.8228 Intermediate Similarity NPC34056
0.8225 Intermediate Similarity NPC472650
0.8221 Intermediate Similarity NPC92979
0.8217 Intermediate Similarity NPC80635
0.8217 Intermediate Similarity NPC243577
0.8217 Intermediate Similarity NPC470741
0.8212 Intermediate Similarity NPC471817
0.821 Intermediate Similarity NPC322546
0.821 Intermediate Similarity NPC308205
0.821 Intermediate Similarity NPC246164
0.821 Intermediate Similarity NPC475777
0.8204 Intermediate Similarity NPC271657
0.8204 Intermediate Similarity NPC259943
0.8199 Intermediate Similarity NPC5180
0.8193 Intermediate Similarity NPC18347
0.8193 Intermediate Similarity NPC149896
0.8193 Intermediate Similarity NPC96443
0.8193 Intermediate Similarity NPC290400
0.8193 Intermediate Similarity NPC200782
0.8187 Intermediate Similarity NPC19747
0.8182 Intermediate Similarity NPC473368
0.8182 Intermediate Similarity NPC310830

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC6326 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8562 High Similarity NPD5760 Phase 2
0.8562 High Similarity NPD5761 Phase 2
0.8242 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD6764 Approved
0.7727 Intermediate Similarity NPD6765 Approved
0.7709 Intermediate Similarity NPD8434 Phase 2
0.7556 Intermediate Similarity NPD6784 Approved
0.7556 Intermediate Similarity NPD6785 Approved
0.7321 Intermediate Similarity NPD920 Approved
0.7216 Intermediate Similarity NPD1247 Approved
0.7202 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD919 Approved
0.7195 Intermediate Similarity NPD1471 Phase 3
0.7168 Intermediate Similarity NPD7819 Suspended
0.7168 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7075 Discontinued
0.7093 Intermediate Similarity NPD6599 Discontinued
0.7083 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.6989 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6982 Remote Similarity NPD7236 Approved
0.6966 Remote Similarity NPD5494 Approved
0.6954 Remote Similarity NPD7411 Suspended
0.6941 Remote Similarity NPD6799 Approved
0.6932 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7799 Discontinued
0.6914 Remote Similarity NPD6801 Discontinued
0.6905 Remote Similarity NPD1243 Approved
0.6879 Remote Similarity NPD7239 Suspended
0.6854 Remote Similarity NPD3749 Approved
0.6836 Remote Similarity NPD3817 Phase 2
0.6831 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6826 Remote Similarity NPD2796 Approved
0.6786 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6786 Remote Similarity NPD6002 Phase 3
0.6786 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6786 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6786 Remote Similarity NPD6005 Phase 3
0.6786 Remote Similarity NPD6004 Phase 3
0.6774 Remote Similarity NPD6559 Discontinued
0.6766 Remote Similarity NPD2799 Discontinued
0.6763 Remote Similarity NPD6273 Approved
0.6758 Remote Similarity NPD3926 Phase 2
0.6743 Remote Similarity NPD3226 Approved
0.6742 Remote Similarity NPD5402 Approved
0.6721 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6719 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6706 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6705 Remote Similarity NPD2534 Approved
0.6705 Remote Similarity NPD2532 Approved
0.6705 Remote Similarity NPD2533 Approved
0.6705 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6704 Remote Similarity NPD3882 Suspended
0.6687 Remote Similarity NPD6832 Phase 2
0.6667 Remote Similarity NPD4628 Phase 3
0.6667 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7184 Clinical (unspecified phase)
0.665 Remote Similarity NPD8404 Phase 2
0.663 Remote Similarity NPD2403 Approved
0.6629 Remote Similarity NPD5403 Approved
0.6613 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6612 Remote Similarity NPD6808 Phase 2
0.6609 Remote Similarity NPD5401 Approved
0.6609 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6608 Remote Similarity NPD2800 Approved
0.6596 Remote Similarity NPD7685 Pre-registration
0.6592 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6588 Remote Similarity NPD5762 Approved
0.6588 Remote Similarity NPD5763 Approved
0.6568 Remote Similarity NPD3748 Approved
0.6557 Remote Similarity NPD8127 Discontinued
0.655 Remote Similarity NPD1549 Phase 2
0.655 Remote Similarity NPD970 Clinical (unspecified phase)
0.6519 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6519 Remote Similarity NPD7057 Phase 3
0.6519 Remote Similarity NPD7058 Phase 2
0.6517 Remote Similarity NPD4380 Phase 2
0.6505 Remote Similarity NPD7473 Discontinued
0.6491 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6491 Remote Similarity NPD2346 Discontinued
0.6491 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6488 Remote Similarity NPD6355 Discontinued
0.6484 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6474 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6471 Remote Similarity NPD3818 Discontinued
0.6468 Remote Similarity NPD7497 Discontinued
0.6467 Remote Similarity NPD7199 Phase 2
0.6467 Remote Similarity NPD8032 Phase 2
0.6467 Remote Similarity NPD6959 Discontinued
0.6463 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6455 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6452 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6452 Remote Similarity NPD6166 Phase 2
0.6452 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6444 Remote Similarity NPD1934 Approved
0.6441 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6437 Remote Similarity NPD3887 Approved
0.6436 Remote Similarity NPD5844 Phase 1
0.6433 Remote Similarity NPD1551 Phase 2
0.6433 Remote Similarity NPD6099 Approved
0.6433 Remote Similarity NPD6100 Approved
0.6429 Remote Similarity NPD7768 Phase 2
0.6421 Remote Similarity NPD7251 Discontinued
0.642 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6407 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6402 Remote Similarity NPD3266 Approved
0.6402 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6402 Remote Similarity NPD3267 Approved
0.64 Remote Similarity NPD4107 Approved
0.6395 Remote Similarity NPD2344 Approved
0.6391 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6387 Remote Similarity NPD7808 Phase 3
0.6386 Remote Similarity NPD7435 Discontinued
0.6383 Remote Similarity NPD3751 Discontinued
0.6379 Remote Similarity NPD3750 Approved
0.6379 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6374 Remote Similarity NPD7033 Discontinued
0.6368 Remote Similarity NPD6797 Phase 2
0.6354 Remote Similarity NPD8313 Approved
0.6354 Remote Similarity NPD8312 Approved
0.635 Remote Similarity NPD8285 Discontinued
0.6344 Remote Similarity NPD3787 Discontinued
0.6344 Remote Similarity NPD7229 Phase 3
0.6344 Remote Similarity NPD5710 Approved
0.6344 Remote Similarity NPD5711 Approved
0.6344 Remote Similarity NPD6232 Discontinued
0.6341 Remote Similarity NPD1876 Approved
0.634 Remote Similarity NPD8150 Discontinued
0.6337 Remote Similarity NPD2935 Discontinued
0.6335 Remote Similarity NPD17 Approved
0.6331 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6321 Remote Similarity NPD8407 Phase 2
0.6316 Remote Similarity NPD7074 Phase 3
0.631 Remote Similarity NPD3268 Approved
0.631 Remote Similarity NPD2313 Discontinued
0.6291 Remote Similarity NPD7907 Approved
0.6287 Remote Similarity NPD4482 Phase 3
0.6284 Remote Similarity NPD5353 Approved
0.6283 Remote Similarity NPD5953 Discontinued
0.6279 Remote Similarity NPD1510 Phase 2
0.6278 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6277 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6265 Remote Similarity NPD1019 Discontinued
0.6265 Remote Similarity NPD5647 Approved
0.6263 Remote Similarity NPD7054 Approved
0.6263 Remote Similarity NPD7286 Phase 2
0.6258 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6257 Remote Similarity NPD6651 Approved
0.6257 Remote Similarity NPD6653 Approved
0.625 Remote Similarity NPD4965 Approved
0.625 Remote Similarity NPD8368 Discontinued
0.625 Remote Similarity NPD4966 Approved
0.625 Remote Similarity NPD2309 Approved
0.625 Remote Similarity NPD4967 Phase 2
0.6235 Remote Similarity NPD4140 Approved
0.6235 Remote Similarity NPD1240 Approved
0.623 Remote Similarity NPD7472 Approved
0.623 Remote Similarity NPD2801 Approved
0.622 Remote Similarity NPD3972 Approved
0.622 Remote Similarity NPD1608 Approved
0.6209 Remote Similarity NPD5890 Approved
0.6209 Remote Similarity NPD5889 Approved
0.6207 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6207 Remote Similarity NPD2353 Approved
0.6205 Remote Similarity NPD6362 Approved
0.6202 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6202 Remote Similarity NPD7874 Approved
0.6201 Remote Similarity NPD1512 Approved
0.6201 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6188 Remote Similarity NPD7458 Discontinued
0.6183 Remote Similarity NPD6234 Discontinued
0.6182 Remote Similarity NPD5327 Phase 3
0.6175 Remote Similarity NPD37 Approved
0.6175 Remote Similarity NPD6279 Approved
0.6175 Remote Similarity NPD6280 Approved
0.617 Remote Similarity NPD7315 Approved
0.6163 Remote Similarity NPD1607 Approved
0.6158 Remote Similarity NPD6779 Approved
0.6158 Remote Similarity NPD6777 Approved
0.6158 Remote Similarity NPD6778 Approved
0.6158 Remote Similarity NPD6776 Approved
0.6158 Remote Similarity NPD6780 Approved
0.6158 Remote Similarity NPD6781 Approved
0.6158 Remote Similarity NPD6782 Approved
0.6157 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6154 Remote Similarity NPD6585 Discontinued
0.6154 Remote Similarity NPD7028 Phase 2
0.6146 Remote Similarity NPD7696 Phase 3
0.6146 Remote Similarity NPD7698 Approved
0.6146 Remote Similarity NPD7697 Approved
0.6141 Remote Similarity NPD1465 Phase 2
0.614 Remote Similarity NPD4307 Phase 2
0.6126 Remote Similarity NPD2163 Approved
0.6126 Remote Similarity NPD7228 Approved
0.6121 Remote Similarity NPD9717 Approved
0.6121 Remote Similarity NPD4111 Phase 1
0.6121 Remote Similarity NPD4665 Approved
0.612 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6118 Remote Similarity NPD3764 Approved
0.6118 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6117 Remote Similarity NPD7871 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data